Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 8-K Event Item 5 · Item 7
  2. 10-Q Report Quarterly Report
  3. 10-Q Report Quarterly Report
  4. DEF 14A Proxy Proxy Statement
  5. 10-K Report Annual Report
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 10-Q Report Quarterly Report
  9. POS AM Other Post-effective Amendment for Registration Statement
  10. S-3 Offering Registration Statement
  11. 8-K/A Event Item 5 · Item 7
  12. 424B3 Offering Prospectus
  13. SC 13G Stake Amended Statement of Ownership
  14. 8-K Event Item 2 · Item 7
  15. 8-K Event Item 5 · Item 7
  16. POS AM Other Post-effective Amendment for Registration Statement
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 10-Q Report Quarterly Report
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 424B3 Offering Prospectus

Page 63 of 65 · 1,298 filings